Top Drug Discovery Companies
1,077 Drug Discovery companies, sorted by total funding raised.

Biotechnology company focused on acquiring, developing and commercializing innovative products in...
Alys Pharmaceuticals is an immuno-dermatology company developing treatments for atopic dermatitis...
AI-powered drug discovery platform
K36 Therapeutics develops selective NSD2 inhibitors, including KTX-1001, to treat cancers driven ...

Harvard-Deerfield joint translational life science R&D company advancing university innovations t...
IconOVir Bio is a biotechnology company pioneering next-generation oncolytic virus therapies to t...

PillPack is an online pharmacy that simplifies medication management by pre-sorting and deliverin...

Orbis Medicines designs oral macrocycle drugs called nCycles using its nGen platform to replace i...
Software therapy deployment platform simplifying prescription management, delivery, and patient a...

TwoStep Therapeutics is developing a pipeline built around a versatile peptide that selectively b...
Regor Therapeutics Group is a clinical-stage biotechnology company that discovers and optimizes p...

Manifold Bio builds a high-throughput in vivo discovery engine that combines multiplexed screenin...

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...
Develops small molecule therapeutics for cancer by reactivating mutant p53

Oral pharmacological chaperone protein therapies to address diseases that result from protein mis...
Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...
A clinical-stage oncology company advancing small molecules that combine both targeted and immune...
Clinical-stage Chinese biopharmaceutical company developing RNA activation (RNAa) and siRNA thera...
Personalized drug discovery for blood cancer.

Pioneer in drug discovery leveraging Kinetic Ensemble platform for oncology precision medicines
Public company, acquired by Bristol Myers Squibb
Abzena helps biotechnology and pharmaceutical innovators develop complex biologics and bioconjuga...
